Company: FCRX
Filing Date: 2025-03-28
Form Type: DEF 14A
Source: 0001133228-25-003192
Chunk: 20

Company: Crescent Capital BDC, Inc.
Filing Date: 2025-03-28
Form: DEF 14A
Chunk 20
---
 Code of Ethics generally does not permit investments by the Corporation’s Directors, officers or any other covered person in securities that may be purchased or held by the Corporation. Additionally, the Rule 17j-1 Code of Ethics generally prohibits the Corporation’s Directors, officers or any other covered person from: (i) buying or selling puts or calls or other derivative securities (other than derivative securities issued by the Corporation, such as convertible notes) based on the Corporation’s securities; (ii) engaging in the short sale of the Corporation’s securities; (iii) holding the Corporation’s securities in a margin account or pledging the Corporation’s securities as collateral for a loan; or (iv) entering into hedging or monetization transactions or similar arrangements with respect to the Corporation’s securities. Requests to receive a copy of the Rule 17j-1 Code of Ethics may be made in writing addressed to Crescent Capital BDC, Inc., 299 Park Avenue, 33rd Floor, New York, NY 10171, Attention: CCAP Investor Relations, or by emailing daniel.mcmahon@crescentcap.com. Insider Trading Policy The Board has adopted an Insider Trading Policy (the “Insider Trading Policy”) governing the purchase, sale and other dispositions of the Corporation’s Common Shares by Directors, officers and employees of the Corporation, among others, that is designed to promote compliance with insider trading laws, rules and regulations. In addition, with regard to the Corporation trading in its own securities, it is the Corporation’s policy to comply with all applicable insider trading laws, rules, and regulations. The Corporation’s Insider Trading Policy is filed as an exhibit to the Corporation’s Annual Report on Form 10-K for the year ended December 31, 2024. The Insider Trading Policy generally prohibits Directors, officers or any other covered person from: (i) buying or selling puts or calls or other derivative securities (other than derivative securities issued by the Corporation, such as convertible notes) based on the Corporation’s securities; (ii) engaging in the short sale of the Corporation’s securities; (iii) holding the Corporation’s securities in a margin account or pledging the Corporation’s securities as collateral for a loan; or (iv) entering into hedging or monetization transactions or similar arrangements with respect to the Corporation’s securities.

14

Involvement
in Certain Legal Proceedings

We
are party to certain lawsuits in the normal course of business, including proceedings relating to the enforcement of our rights under
loans to or other contracts with